Pharmacokinetic Study of Allisartan Isoproxil Tablets in Healthy Chinese Participants

NCT07174830 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Allisartan Isoproxil Tablets 240mg or placebo
DRUG: Allisartan Isoproxil Tablets 480mg or placebo
DRUG: Allisartan Isoproxil Tablets 720mg or placebo

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.